Moderna Enters the Cancer Treatment Market with Highly Effective Skin Cancer Therapy

Cambridge, Friday, 17 April 2026.
Moderna will showcase new skin cancer therapy data revealing an impressive 83% response rate, signaling the company’s strategic and lucrative expansion into oncology beyond its post-pandemic pipeline.